Differentiation fate of a stem-like CD4 T cell controls immunity to cancer
Nature · 05.12.2024 · 636 (8041) · 224-232
DOI: 10.1038/s41586-024-08076-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 23.10.2024. Verfasst von Maria A Cardenas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Cell Differentiation, Immunotherapy, Kidney Neoplasms. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
The T cell response to cancer controls disease progression and response to immunotherapy1-3. Despite extensive knowledge regarding CD8 T cells, how CD4 T cells contribute to this process is less well understood. Here we identified a population of PD1+TCF1+ CD4 T cells with stem-like properties that are capable of self-renewal and differentiation into canonical CD4 effector cells. Primarily residing in tumour-draining lymph nodes (TDLNs), these tumour-specific CD4 T cells are restricted by T regulatory (Treg) cells to a stem-like fate that predominantly generated induced Treg (iTreg) cells, limiting effector CD8 T cell responses to the tumour. By contrast, upon Treg depletion, stem-like CD4 T cells differentiated into T helper 1 (TH1) cells, and via IFNγ production induced robust effector differentiation from TCF1+ CD8 T cells in TDLNs, a state we defined as 'active'. Notably, enforcing TBET expression in transferred stem-like CD4 T cells was sufficient to overcome the established restricted T cell state. Despite the presence of Treg cells, endogenous stem-like CD4 T cells actively generated TH1 cells, which were required to restore TDLN effector CD8 T cell differentiation, enhance tumour control and rescue response to immunotherapy. In agreement, TH1 differentiation in patients with kidney cancer predicted successful immunotherapy responses and improved progression-free survival. Together, these findings identify a stem-like CD4 T cell population that through alternative differentiation fates controls the switch between restricted and active T cell states with implications for cancer immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
- Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
- Winship Cancer Institute of Emory University, Atlanta, GA, USA.
- Department of Urology, Emory University School of Medicine, Atlanta, GA, USA. haydn.kissick@emory.edu.
- Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. haydn.kissick@emory.edu.
ORCID-Profile: Rachel Greenwald, Vikram M Narayan, Haydn T Kissick
Förderung
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Cardenas, M. A., Prokhnevska, N., Sobierajska, E., Gregorova, P., Medina, C. B., Valanparambil, R. M., Greenwald, R., DelBalzo, L., Bilen, M. A., Joshi, S. S., Narayan, V. M., Master, V. A., Sanda, M. G., & Kissick, H. T. (2024). Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature, 636(8041), 224-232. https://doi.org/10.1038/s41586-024-08076-7
Vancouver
Cardenas MA, Prokhnevska N, Sobierajska E, Gregorova P, Medina CB, Valanparambil RM, et al. Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature. 2024;636(8041):224-232. doi:10.1038/s41586-024-08076-7
BibTeX
@article{Cardenas2024,
author = {Cardenas, Maria A and Prokhnevska, Nataliya and Sobierajska, Ewelina and Gregorova, Petra and Medina, Christopher B and Valanparambil, Rajesh M and Greenwald, Rachel and DelBalzo, Luke and Bilen, Mehmet Asim and Joshi, Shreyas S and Narayan, Vikram M and Master, Viraj A and Sanda, Martin G and Kissick, Haydn T},
title = {Differentiation fate of a stem-like CD4 T cell controls immunity to cancer},
journal = {Nature},
year = {2024},
volume = {636},
number = {8041},
pages = {224--232},
doi = {10.1038/s41586-024-08076-7}
}
EUVIMED